Segall Bryant & Hamill LLC Takes Position in Select Medical Holdings Co. (NYSE:SEM)

Segall Bryant & Hamill LLC purchased a new position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 79,343 shares of the health services provider's stock, valued at approximately $2,767,000. Segall Bryant & Hamill LLC owned approximately 0.06% of Select Medical at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of SEM. GAMMA Investing LLC raised its stake in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock worth $81,000 after purchasing an additional 330 shares during the period. Foster & Motley Inc. increased its stake in shares of Select Medical by 3.1% in the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider's stock worth $426,000 after buying an additional 370 shares during the period. KBC Group NV lifted its stake in Select Medical by 4.5% in the third quarter. KBC Group NV now owns 13,050 shares of the health services provider's stock worth $455,000 after acquiring an additional 563 shares during the period. Arizona State Retirement System raised its position in shares of Select Medical by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider's stock worth $1,071,000 after acquiring an additional 593 shares in the last quarter. Finally, Hexagon Capital Partners LLC boosted its stake in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider's stock worth $27,000 after acquiring an additional 645 shares in the last quarter. 89.48% of the stock is owned by institutional investors.

Select Medical Stock Up 1.5 %

Shares of SEM stock traded up $0.60 during trading on Friday, reaching $39.67. The company's stock had a trading volume of 1,011,826 shares, compared to its average volume of 765,580. The stock's 50-day moving average price is $35.19 and its 200 day moving average price is $35.02. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a 1-year low of $22.26 and a 1-year high of $40.98. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 18.54, a P/E/G ratio of 1.75 and a beta of 1.42.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the firm earned $0.46 EPS. Select Medical's revenue for the quarter was up 5.7% on a year-over-year basis. On average, research analysts anticipate that Select Medical Holdings Co. will post 2.16 EPS for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 1.26%. The ex-dividend date of this dividend is Wednesday, November 13th. Select Medical's payout ratio is 23.36%.

Analyst Upgrades and Downgrades

Several brokerages have commented on SEM. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. StockNews.com lowered shares of Select Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Benchmark reiterated a "buy" rating and issued a $48.00 target price on shares of Select Medical in a report on Friday, November 1st. Finally, Bank of America initiated coverage on shares of Select Medical in a research note on Tuesday, August 20th. They set a "buy" rating and a $42.00 price target for the company. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $40.75.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.